Use of type I and type IV hypersensitivity responses to define the immunopharmacological profile of drugs-Reference-Cited by-同舟云学术

Use of type I and type IV hypersensitivity responses to define the immunopharmacological profile of drugs

Published:1997-03 Issue:2 Volume:37 Page:91-96
ISSN:1056-8719
Container-title:Journal of Pharmacological and Toxicological Methods
language:en
Short-container-title:Journal of Pharmacological and Toxicological Methods

Author:

Pierro Francesco Di,d'Atri Gaetano,Marcucci Fabrizio,Leoni Flavio

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference30 articles.

1. The mechanisms of action of nonsteroidal antiinflammatory drugs;Abramson;Arth Rheum,1989

2. Anaphylactic shock: Catecholamine actions in response to opioid antagonist;Amir;Prog. Clin Biol Res,1988

3. Evaluation of the in vivo dose-response relationship of immunosuppressive drugs using a mouse heart transplant model: application to cyclosporin;Babany;J Pharmacol Exp Ther,1988

4. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection;Bartlett;Agents Actions,1991

5. Drug dosage in laboratory animals: A handbook;Borchard,1992

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation and Immunity as Targets for Drug Therapy in Acute Coronary Syndrome;Acute Coronary Syndromes: A Companion to Braunwald's Heart Disease;2011

2. Probable cutaneous hypersensitivity to carboplatin single-agent chemotherapy in a dog;Journal of Small Animal Practice;2010-12

3. Oxazolone-Induced Delayed Type Hypersensitivity Reaction in the Adult Yucatan Pigs. A Useful Model for Drug Development and Validation;Toxins;2009-08-21

4. Modeling of delayed type hypersensitivity (DTH) in the non-human primate (NHP);Drug Discovery Today: Disease Models;2008-06

5. The Novel JAK-3 Inhibitor CP-690550 Is a Potent Immunosuppressive Agent in Various Murine Models;American Journal of Transplantation;2004-01